Posted on

How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy

In 2004, Gilead Sciences decided to stop pursuing a new H.I.V. drug. The public explanation was that it wasn’t sufficiently different from an existing treatment to warrant further development.In private, […]




Posted on

Merck Sues Over Medicare Drug-Price Negotiation Law

The pharmaceutical company Merck on Tuesday sued the government over a federal law that empowers Medicare for the first time to negotiate prices directly with drugmakers.Merck’s lawsuit, filed in federal […]




Posted on

Bosses Have a New Headache: How Long Should Sick Workers Isolate?

Barbara Sibley’s four New York restaurants had already weathered the city’s initial Covid-19 wave, the prevaccine surge last winter and this summer’s Delta spike when last weekend it finally happened: […]